5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial
Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Jodi J. Akin(Edwards Lifesciences (United States)), Joseph E. Bavaria(University of Pennsylvania), William N. Anderson(Edwards Lifesciences (United States)), Vasilis Babaliaros(Valve (United States)), E. Murat Tuzcu(Cleveland Clinic), Susheel Kodali(Columbia University Irving Medical Center), D. Craig Miller(Harvard University), Lars G. Svensson(Cleveland Clinic), John G. Webb(St. Paul's Hospital), Raj Makkar(Cedars-Sinai Medical Center), Rebecca T. Hahn(Columbia University Irving Medical Center), Pamela S. Douglas(Duke University), Jeffrey W. Moses(Good Samaritan University Hospital), Howard C. Herrmann(University of Pennsylvania), Gregory P. Fontana(HCA Healthcare), Mathew Williams(Mount Sinai Health System), Samir Kapadia(Cleveland Clinic), David L. Brown(Baylor Scott & White Health), Martin B. Leon(Columbia University Irving Medical Center), Craig R. Smith(University of Arizona), Michael Davidson(University of California, Los Angeles), Eugene H. Blackstone(Cleveland Clinic), Augusto D. Pichard(MedStar Washington Hospital Center), Vinod H. Thourani(Valve (United States))
Cited by 1,752
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
EuroSCORE II
|European Journal of Cardio-Thoracic Surgery|2012|2.9k